Companies List
BioNumerik Pharmaceuticalsl
 

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

BioNumerik Pharmaceuticals crunches the numbers to develop drugs that fight cancer and the side effects often associated with many therapies. The company has two late-stage drugs in development. Lead candidate Tavocept, which has FDA fast-track status, may prevent nerve and kidney damage caused by cancer therapies. The firm is developing the drug with the cancer unit of Baxter and through a joint venture with an affiliate of Takeda Pharmaceutical Company. BioNumerik's BNP1350 (aka karenitecin) candidate is an advanced formulation of an existing cancer drug that may defeat drug-resistant tumors.
   
Key People
• Chairman and CEO: Frederick H. Hausheer
• VP and CFO: Steven W. Riebel
• VP, Information Systems and Technologies: Michael F. Moloney


Contact Information
Address: 8122 Datapoint Dr., Ste. 1250
San Antonio, TX 78229
Phone: 210-614-1701
Fax: 210-615-8030



Top Competitors
• Aventis Pharmaceuticals Inc.
• Sepracor Inc. (SEPR)

Industry Information
Sector: Pharmaceuticals
Industry: Biotechnology :-Biopharmaceuticals & Biotherapeutics (primary)
 
 
 
 
    Sponsors Links
Online Pharmacy
Allergies, Pain, Burn, Women Health, Mens Health, all kind of drug available.
londondrugmart.com

Medicine Store
Clinically proven, professional quality medicines
epsdrugstore.com

    Popular Searches
Lexapro

Viagra

Cialis

Levitra

Zoloft

Lose Weight

Pain Relief

    Advertisement



 
 


Copyright © 2008 Medical Information All Rights Reserved.